Bayer AG (BAYRY-OTC)
OTCMKTS:BAYRY
6.02
Financials
Technical Analysis
Related posts
Battle of the Top Dividend ETFs : CanadaThis summary was created by AI, based on 2 opinions in the last 12 months.
Bayer AG (BAYRY) has faced significant challenges in recent years, primarily stemming from litigation related to its Monsanto business and concerns over the safety of its Roundup weedkiller products. However, a recent favorable court ruling dismissed claims that suggested these products increase cancer risk, resulting in a notable stock price jump of over 10%. Despite this positive momentum, the company's growth projections remain modest while it continues to grapple with a high debt load. In the recent quarterly results, Bayer reported positive earnings that exceeded expectations and affirmed its full-year guidance, yet some analysts exercise caution due to the ongoing legal risks and overall industry sentiment. As the stock trades at a low valuation of 5.5 times forward earnings, experts are divided on the potential for future appreciation, with some advocating for careful risk management.
It is priced at 50 cents on the dollar compared to its peers. In 2018 it bought Monsanto and the Roundup litigation halved the company. However it is being dealt with. It has three new drugs on the pharma side, one with no near term competitors when it comes off patent. It will probably spin out the herbicide business and sits at a very attractive price. Buy 18 Hold 8 Sell 1
- «
- ‹
- 1
- ›
- »
Bayer AG(BAYRY-OTC) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 1
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 1
Total Signals / Votes : 2
Bayer AG(BAYRY-OTC) Frequently Asked Questions
What is Bayer AG stock symbol?
Bayer AG is a American stock, trading under the symbol BAYRY-OTC on the US OTC (BAYRY). It is usually referred to as OTC:BAYRY or BAYRY-OTC
Is Bayer AG a buy or a sell?
In the last year, 2 stock analysts published opinions about BAYRY-OTC. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Bayer AG.
Is Bayer AG a good investment or a top pick?
Bayer AG was recommended as a Top Pick by on . Read the latest stock experts ratings for Bayer AG.
Why is Bayer AG stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Bayer AG worth watching?
2 stock analysts on Stockchase covered Bayer AG In the last year. It is a trending stock that is worth watching.
What is Bayer AG stock price?
On 2025-03-31, Bayer AG (BAYRY-OTC) stock closed at a price of $6.02.
There was some positive news on the 16th, after a US court ruled in favor of its Monsanto business in a lawsuit alleging that BAYRY's Roundup weedkiller products increase the risk of cancer. These claims were dismissed and the stock jumped over 10% that day. Recent quarterly results were positive and it beat on earnings and affirmed full-year guidance. It continues to be very cheap at 5.5x forward earnings but growth is not expected to be high while debt is also very high. We continue to not be overly excited here.
Unlock Premium - Try 5i Free